Bioventus (BVS) Other Non-Current Assets (2021 - 2022)
Bioventus posted quarterly Other Non-Current Assets of $2.8 million for Q4 2022, down 94.45% year-on-year from $50.0 million in Q4 2021, and down 94.45% on a QoQ basis from $50.0 million in Q2 2022.
Bioventus (BVS) has 2 years of Other Non-Current Assets data on file, last reported at $2.8 million in Q4 2022.
- For the quarter ending Q4 2022, Other Non-Current Assets fell 94.45% year-over-year to $2.8 million; the trailing twelve-month figure through Dec 2022 stood at $2.8 million (down 94.45% YoY), and the FY2022 full-year result was $2.8 million, down 94.45% from the prior year.
- Other Non-Current Assets for Q4 2022 stood at $2.8 million, down from $50.0 million in the prior quarter.
- Across five years, Other Non-Current Assets topped out at $50.0 million in Q4 2021 and bottomed at $2.8 million in Q4 2022.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | - |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 3.17 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 4.04 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 44.35 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 738.90 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 140.49 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 285.90 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 2.25 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 211.40 Mn |
| 10 | Bioventus | 535.01 Mn | 544.52 Mn | 90.77 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 2.78 Mn |
| Apr 2, 2022 | 50.00 Mn |
| Dec 31, 2021 | 50.00 Mn |
| Oct 2, 2021 | 50.00 Mn |